Collegium Pharmaceutical, Inc. COLL Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Collegium Pharmaceutical, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s return on equity?
- Collegium Pharmaceutical, Inc. (COLL) reported return on equity of 27.4% in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s return on equity changed year-over-year?
- Collegium Pharmaceutical, Inc.'s return on equity increased by 42.6% year-over-year, from 19.2% to 27.4%.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s return on equity?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s return on equity has grown at a 3.9% compound annual growth rate (CAGR), from 19.6% to 23.7%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.